APA (7th ed.) Citation

Meis, S., Hamacher, A., Hongwiset, D., Marzian, C., Wiese, M., Eckstein, N., . . . Kassack, M. U. (2010). NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells. The Journal of pharmacology and experimental therapeutics, 332(1), 238-247. https://doi.org/10.1124/jpet.109.157750

Chicago Style (17th ed.) Citation

Meis, Sabine, et al. "NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells." The Journal of Pharmacology and Experimental Therapeutics 332, no. 1 (2010): 238-247. https://doi.org/10.1124/jpet.109.157750.

MLA (9th ed.) Citation

Meis, Sabine, et al. "NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells." The Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 1, 2010, pp. 238-247, https://doi.org/10.1124/jpet.109.157750.